A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2002
11/07/2002	WO2002088110A1 Quinoline derivative having azolyl group and quinazoline derivative
11/07/2002	WO2002088107A1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
11/07/2002	WO2002088097A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002	WO2002088095A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	WO2002088090A2 Pyrazole derived kinase inhibitors
11/07/2002	WO2002088084A1 Heterocyclic compound derivatives and medicines
11/07/2002	WO2002088080A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002088079A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002088061A1 Novel atisane compound and use thereof
11/07/2002	WO2002087626A1 Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same
11/07/2002	WO2002087607A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
11/07/2002	WO2002087596A2 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
11/07/2002	WO2002087593A1 A method for treating or preventing a functional vitamin b12 deficiency in an individual and to medical compositions for use in said method
11/07/2002	WO2002087583A2 Use of hiv-protease inhibitors to block cell migration and/or invasion, tissue infiltration and oedema formation
11/07/2002	WO2002087576A1 The treatment of scarring and related conditions using ppar-gamma activators
11/07/2002	WO2002087569A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
11/07/2002	WO2002087565A1 Inhibition of pigmentation by inhibition of fatty acid synthase
11/07/2002	WO2002087548A1 A pharmaceutical tablet having a high api content
11/07/2002	WO2002087534A2 Cosmetic or dermatological formulations having a content of sericoside
11/07/2002	WO2002087533A1 Use of a clover extract for prophylaxis against and for treating degenerative skin conditions
11/07/2002	WO2002087532A2 Cosmetic or dermatological formulations having a content of sericoside
11/07/2002	WO2002087513A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002	WO2002087511A2 Modulators of elastase inhibitor secretion
11/07/2002	WO2002087508A2 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/07/2002	WO2002087424A2 Treatment and diagnosis of macrophage mediated disease
11/07/2002	WO2002074980A3 Muteins of hypoxia inducible factor alpha and methods of use thereof
11/07/2002	WO2002055096A3 Local use of essential oils for treating badly healed wounds
11/07/2002	WO2002051352A3 New uses of insulin and pancreatin
11/07/2002	WO2002028424A3 Kyberdrug as autovaccines with immune-regulating effects
11/07/2002	WO2002009768A3 Therapeutic polyesters and polyamides
11/07/2002	WO2001086002A9 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
11/07/2002	WO2001027079A9 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease
11/07/2002	WO2000064420A3 Compositions and methods for treating amyloidosis using sulphonate derivatives
11/07/2002	US20020165412 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/07/2002	US20020165399 Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists
11/07/2002	US20020165377 ADAM polynucleotides, polypeptides, and antibodies
11/07/2002	US20020165374 Secreted protein HFEAF41
11/07/2002	US20020165343 Growth hormone secretagogues
11/07/2002	US20020165286 Lipophilic excipient capable of dissolving the drug, targeting to the pilosebaceous ducts on the skin; antiacne
11/07/2002	US20020165275 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/07/2002	US20020165262 Methods and products relating to 16-HETE analogs
11/07/2002	US20020165260 Compositions and methods for the treatment and prevention of bovine mastitis
11/07/2002	US20020165230 Gamma-ketoacid dipeptides as inhibitors of caspase-3
11/07/2002	US20020165214 Cosmetic or dermatological use of 7-hydroxylated steroids
11/07/2002	US20020165203 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents
11/07/2002	US20020165202 Antiinflammatory agents; antiproliferative agents
11/07/2002	US20020165197 Administering adenosine receptor ligand
11/07/2002	US20020165186 Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/07/2002	US20020165170 Antagonists that bind CD1d and inhibit activation of CD1d-restricted natural killer (NK) T cells, agents that block CD1d-specific receptors and CD1d decoys and a carrier or diluent; contact dermatitis for example
11/07/2002	US20020165168 Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances
11/07/2002	US20020165164 New effectors of dipeptidyl peptidase IV for topical use
11/07/2002	US20020165150 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors
11/07/2002	US20020165133 Use of [gamma-hydroxy-N-methyl-leucine9] cyclosporin a for hair growth
11/07/2002	US20020165131 Histidine-rich glycoprotein
11/07/2002	US20020164767 DNA encoding the human serine protease C-E
11/07/2002	US20020164734 Human pelota homolog
11/07/2002	US20020164682 Mammalian cerberus-like protein and compositions
11/07/2002	US20020164390 Compositions containing an active fraction isolated from tricholoma conglobatum and methods of use
11/07/2002	US20020164386 Topical applying glucosamine containing cream
11/07/2002	US20020164384 Aquatic animal treatment method and composition containing pimenta extract
11/07/2002	US20020164381 Mixture containing sulfur and sulfur compound
11/07/2002	US20020164360 Topical applying peptide to skin
11/07/2002	US20020164349 Induction apoptosis; west nile virus therapy
11/07/2002	US20020164303 Administering nucleic acids to muscle tissue
11/07/2002	DE10121252A1 Behandlung der Akne Treatment of acne
11/07/2002	CA2447748A1 Use of hiv-protease inhibitors to block cell migration and/or invasion, tissue infiltration and oedema formation
11/07/2002	CA2446514A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	CA2446079A1 Modulators of elastase inhibitor secretion
11/07/2002	CA2446064A1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/07/2002	CA2445839A1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
11/07/2002	CA2445826A1 Treatment and diagnosis of macrophage mediated disease
11/07/2002	CA2445702A1 Control of compactability through crystallization
11/07/2002	CA2445568A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002	CA2445376A1 Substance rkb-3564 having angiogenesis inhibitory action
11/07/2002	CA2445357A1 Pyrazole derived kinase inhibitors
11/07/2002	CA2445348A1 Novel benzylpiperidine compound
11/07/2002	CA2445338A1 G-protein coupled receptors
11/07/2002	CA2445298A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
11/07/2002	CA2445294A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
11/07/2002	CA2445290A1 A pharmaceutical tablet having a high api content
11/07/2002	CA2444911A1 Fusion molecules and methods for treatment of immune diseases
11/07/2002	CA2444436A1 Dual inhibitors of pde 7 and pde 4
11/07/2002	CA2443835A1 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002	CA2443381A1 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
11/07/2002	CA2440775A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/06/2002	EP1255112A2 Treatment of T-cell mediated diseases
11/06/2002	EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides
11/06/2002	EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
11/06/2002	EP1254251A2 Neurosteroids as markers for alzheimer's disease
11/06/2002	EP1254246A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/06/2002	EP1254235A2 Drug metabolizing enzymes
11/06/2002	EP1254212A2 Methods of preparing and using a viral vector library
11/06/2002	EP1254174A2 Human cyr61
11/06/2002	EP1254138A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
11/06/2002	EP1254137A1 PYRIDO 2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS
11/06/2002	EP1254134A2 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors
11/06/2002	EP1254130A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/06/2002	EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002	EP1254119A1 Pyrimidine derivatives as selective inhibitors of cox-2
11/06/2002	EP1254116A1 Alpha v integrin receptor antagonists

1 ... 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 ... 1065